Fresenius Medical Care AG & Co KGaA (FME) - Financial and Strategic SWOT Analysis Review
Description
Fresenius Medical Care AG & Co KGaA (FME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Fresenius Medical Care AG & Co KGaA (Fresenius Medical Care) is an integrated dialysis company. It provides dialysis care services and products to individuals with chronic kidney failure. The company develops and manufactures an array of dialysis machines, systems, and disposable products. Fresenius Medical Care also offers care coordination services including pharmacy services, vascular, cardiovascular, and endovascular specialty, non-dialysis laboratory testing, physician, hospitalist and intensivist, and health plan services and urgent care services. The company provides dialysis treatment at its clinics and sells its products to other dialysis service providers. It conducts operations through subsidiaries in Europe, the Middle East, Africa, the Americas and Asia-Pacific. Fresenius Medical Care is headquartered in Bad Homburg, Germany.
Fresenius Medical Care AG & Co KGaA Key Recent Developments
Oct 01,2025: Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement
Aug 05,2025: Fresenius Medical Care Delivers Strong Organic Revenue Growth and Double-Digit Operating Income Growth in the Second Quarter of 2025
Jul 31,2025: Fresenius Medical Care’s Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
Jul 31,2025: Azenta Life Sciences Partners With Frenova, a Division of Fresenius Medical Care, and Nephronomics To Advance Genomic Research in Nephrology
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Fresenius Medical Care AG & Co KGaA (Fresenius Medical Care) is an integrated dialysis company. It provides dialysis care services and products to individuals with chronic kidney failure. The company develops and manufactures an array of dialysis machines, systems, and disposable products. Fresenius Medical Care also offers care coordination services including pharmacy services, vascular, cardiovascular, and endovascular specialty, non-dialysis laboratory testing, physician, hospitalist and intensivist, and health plan services and urgent care services. The company provides dialysis treatment at its clinics and sells its products to other dialysis service providers. It conducts operations through subsidiaries in Europe, the Middle East, Africa, the Americas and Asia-Pacific. Fresenius Medical Care is headquartered in Bad Homburg, Germany.
Fresenius Medical Care AG & Co KGaA Key Recent Developments
Oct 01,2025: Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement
Aug 05,2025: Fresenius Medical Care Delivers Strong Organic Revenue Growth and Double-Digit Operating Income Growth in the Second Quarter of 2025
Jul 31,2025: Fresenius Medical Care’s Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
Jul 31,2025: Azenta Life Sciences Partners With Frenova, a Division of Fresenius Medical Care, and Nephronomics To Advance Genomic Research in Nephrology
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
Table of Contents
70 Pages
- Section 1 - About the Company
- Fresenius Medical Care AG & Co KGaA - Key Facts
- Fresenius Medical Care AG & Co KGaA - Key Employees
- Fresenius Medical Care AG & Co KGaA - Key Employee Biographies
- Fresenius Medical Care AG & Co KGaA - Major Products and Services
- Fresenius Medical Care AG & Co KGaA - History
- Fresenius Medical Care AG & Co KGaA - Company Statement
- Fresenius Medical Care AG & Co KGaA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Fresenius Medical Care AG & Co KGaA - Business Description
- Business Segment: Care Delivery
- Overview
- Performance
- Business Segment: Care Enablement
- Overview
- Performance
- Geographical Segment: Germany
- Performance
- Geographical Segment: Rest of the world
- Performance
- Geographical Segment: U.S.
- Performance
- R&D Overview
- Fresenius Medical Care AG & Co KGaA - Corporate Strategy
- Fresenius Medical Care AG & Co KGaA - SWOT Analysis
- SWOT Analysis - Overview
- Fresenius Medical Care AG & Co KGaA - Strengths
- Fresenius Medical Care AG & Co KGaA - Weaknesses
- Fresenius Medical Care AG & Co KGaA - Opportunities
- Fresenius Medical Care AG & Co KGaA - Threats
- Fresenius Medical Care AG & Co KGaA - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2019 to YTD 2025
- Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Type, 2019 to YTD 2025
- Fresenius Medical Care AG & Co KGaA, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Oct 01, 2025: Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement
- Aug 05, 2025: Fresenius Medical Care Delivers Strong Organic Revenue Growth and Double-Digit Operating Income Growth in the Second Quarter of 2025
- Jul 31, 2025: Fresenius Medical Care’s Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
- Jul 31, 2025: Azenta Life Sciences Partners With Frenova, a Division of Fresenius Medical Care, and Nephronomics To Advance Genomic Research in Nephrology
- Jul 03, 2025: Fresenius Medical Care Joins Forces With Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
- Jun 17, 2025: Fresenius Medical Care Launches Its Strategy FME Reignite With Increased Profitability Aspirations, and a New Capital Allocation Framework to Further Enhance Value Creation
- May 30, 2025: Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025
- May 06, 2025: Fresenius Medical Care Starts 2025 With Strong Organic Revenue and Income Growth
- Mar 13, 2025: Fresenius Medical Care Releases 2024 Annual Report
- Jan 10, 2025: Fresenius Medical Care Supports Patients and Staff During the Wildfires in Southern California
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Fresenius Medical Care AG & Co KGaA, Key Facts
- Fresenius Medical Care AG & Co KGaA, Key Employees
- Fresenius Medical Care AG & Co KGaA, Key Employee Biographies
- Fresenius Medical Care AG & Co KGaA, Major Products and Services
- Fresenius Medical Care AG & Co KGaA, History
- Fresenius Medical Care AG & Co KGaA, Subsidiaries
- Fresenius Medical Care AG & Co KGaA, Key Competitors
- Fresenius Medical Care AG & Co KGaA, Ratios based on current share price
- Fresenius Medical Care AG & Co KGaA, Annual Ratios
- Fresenius Medical Care AG & Co KGaA, Annual Ratios (Cont...1)
- Fresenius Medical Care AG & Co KGaA, Annual Ratios (Cont...2)
- Fresenius Medical Care AG & Co KGaA, Interim Ratios
- Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2019 to YTD 2025
- Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Type, 2019 to YTD 2025
- Fresenius Medical Care AG & Co KGaA, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Fresenius Medical Care AG & Co KGaA, Performance Chart (2020 - 2024)
- Fresenius Medical Care AG & Co KGaA, Ratio Charts
- Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2019 to YTD 2025
- Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals by Type, 2019 to YTD 2025
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


